BCS
Barclays plc ADR
$27.77+1.83%
Setup
Watch
Buy Zone
$28.84-$30.28
Sector
Banks - Diversified
Industry
Banks - Diversified
51
Recommendation
Extended
Avoid
Setup may be valid but price is no longer in a clean buy zone.
BCS chart
Loading chart…
Overall Quality51
RS Rating
77
relative strength
Fundamentals
74
Solid fund-Q
Volume Demand
82
-2% vs avg
Technical Setup
75
6/8 checks
Industry/Theme
91
Banks - Diversified
Trade Plan
Extended
Entry
$28.84
Entry Zone
$28.84-$30.28
Stop / Risk
$26.53
RS Rating
77
Volume confirmed
Yes
Targets
$34.61 / $36.05
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $28.84–$30.28Stop $26.53Target $34.61 / $36.05
Market regimeRange
Quality51
RS Rating77
Above 50-MA+13.32%
Above 200-MA+18.59%
VolumeConfirmed
In Buy ZoneNo
Not extendedExtended
Invalidation · Close below stop
How this came together
51
MarketRange
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q74 · Solid
StatusAvoid
Stock Data
52-Week Range18 – 28
Price % Chg YTD9.12%
Price % Chg 4wk9.85%
50-Day Avg Vol6.0 Mil
P/E Ratio10.9
Market Cap$90B
SectorFinancial
IndustryBanks - Diversified
Company Fundamentals
EPS % Chg (Qtr)15.64%
Sales % Chg (Qtr)13.29%
EPS Growth 5y38.51%
Sales Growth 5y15.25%
Annual ROE10.22%
Gross Margin—
Operating Margin32.76%
Net Margin21.1%
Debt / Equity3.08
Setup levels
Current price
$27.77
Pivot
$28.84
Distance to buy
+0.3%
52-week range
17.73-27.7
Trigger evidence
No active trigger evidence available.
Pattern levels: near highs
Financial health checks
3/5
Return on equity above 15%
ROE 10.22%
Net margin above 10%
Net margin 21.1%
EPS growing quarter on quarter
EPS q/q 15.64%
Sales growing quarter on quarter
Sales q/q 13.29%
Debt to equity below 1.0
D/E 3.08
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE10.22%
vs sector -2.8%
Net margin21.1%
vs sector +2.5%
Gross margin—
EPS growth q/q15.64%
vs sector -7.2%
Sales growth q/q13.29%
vs sector -0.8%
Debt / equity3.08
vs sector +0.63
Business quality
74
GradeSolid
EPS rating62
P/E10.9
Market cap$90B
IndustryBanks - Diversified
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Pass
Volumen bestätigt
Pass
In Kaufzone
Fail
Nicht überextended
Fail
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-07-02
Trigger date
—
Days on list
2
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.